SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
03-Apr-24 8:47 PM View: | Metagenomi, Inc. (MGX) | 01-Apr-24 | Grant | 57,763 | -- | -- | 136% 42.61K to 100.37K | |
19-Jan-24 4:28 PM View: | Marinus Pharmaceuticals, Inc. (MRNS) | 18-Jan-24 | Grant | 4,600 | -- | -- | 64% 7.2K to 11.8K | |
17-May-23 9:08 PM View: | Marinus Pharmaceuticals, Inc. (MRNS) | 16-May-23 | Grant | 7,200 | -- | -- | 100% 0 to 7.2K | |
12-Feb-21 6:36 PM View: | Protagonist Therapeutics, Inc (PTGX) | 11-Feb-21 | Grant | 3,700 | $6.98 | $25,826.00 | 100% 0 to 3.7K | |
12-Feb-21 6:36 PM View: | Protagonist Therapeutics, Inc (PTGX) | 11-Feb-21 | Market Sale (Planned) | 3,700 | $25.09 | $92,833.00 | (100%) 3.7K to 0 | |
12-Feb-21 6:36 PM View: | Protagonist Therapeutics, Inc (PTGX) | 10-Feb-21 | Grant | 4,700 | $6.98 | $32,806.00 | 100% 0 to 4.7K | |
12-Feb-21 6:36 PM View: | Protagonist Therapeutics, Inc (PTGX) | 10-Feb-21 | Market Sale (Planned) | 4,700 | $25.47 | $119,722.00 | (100%) 4.7K to 0 |